
-
Supreme Pogacar wins Tour de France for fourth time
-
Verstappen accuses race organisers of being overcautious with rain delay
-
Sundar and Jadeja follow Gill's lead as defiant India draw fourth Test with England
-
Piastri turns personal disappointment into motivation to win at Spa
-
Bayern agree deal to sign Liverpool winger Diaz: reports
-
WHO says malnutrition reaching 'alarming levels' in Gaza
-
Russia's Egorian wins world fencing gold as neutral athlete
-
Greece wildfires abating as firefighters contain outbreaks
-
Competitive element of Tour de France final stage removed after rain
-
Piastri holds off Norris at Spa, extends championship lead
-
Piastri wins Belgian GP, extends championship lead
-
Late Odegaard penalty gives Arsenal 3-2 win over Newcastle
-
Sundar and Jadeja follow Gill's lead as India frustrate England in fourth Test
-
Thais and Cambodians refuse to quit homes on clash frontier
-
Food airdropped into Gaza as Israel says opening aid routes
-
Godzilla fans fete the monster as it turns 70
-
Rashford makes Barcelona debut in Japan friendly win
-
Spanish veteran Garcia wins stage 2 of women's Tour de France
-
McIntosh makes golden start as Australia win world relay double
-
Rain delays start to Belgian Grand Prix
-
Chinese swimmer reaches world championships final aged 12
-
McIntosh 'in shape of my life' after romping to first Singapore gold
-
England see off record-breaker Gill as they push for India series win
-
Maertens hails German success after world 400m freestyle gold
-
Thailand and Cambodia to hold peace talks after more border clashes
-
McIntosh romps to world 400m freestyle gold, Ledecky third
-
Stokes strikes as England finally see off India's KL Rahul in fourth Test
-
Maertens wins thrilling world 400m men's freestyle gold
-
Questions swell in Eswatini over five men deported from US
-
Activist boat Handala seized off Gaza brought to Israel
-
Humanoid robots embodiment of China's AI ambitions
-
Israel says opening routes into Gaza to increase food aid
-
Greece gets EU help to battle disastrous wildfires
-
Pogacar leads peloton into Paris for Tour de France climax
-
Trump's Turnberry visit puts British Open back on agenda
-
Israel declares Gaza fighting pause amid deepening hunger crisis
-
McIntosh launches bid for world domination as Ledecky fires warning
-
Australia beat WIndies by three wickets in fourth T20I match
-
Kalinskaya meets Fernandez, De Minaur faces Spaniard in DC finals
-
Iraqi women table tennis players chase Paralympic dreams
-
Urgent need for 'global approach' on AI regulation: UN tech chief
-
Amateur football leagues win over cynical Chinese fans
-
US Fed poised to hold off on rate cuts, defying Trump pressure
-
Battling tariffs is no trivial pursuit for US games retailer
-
Ecuador deports more than 600 Colombian inmates as Bogota cries foul
-
Trump, EU chief seek deal in transatlantic tariffs standoff
-
Wallabies hire New Zealand's Donnelly to help Schmidt
-
New Zealand farmers battle pine forests to 'save our sheep'
-
Wallabies will not 'wallow in self-pity' after crushing Lions loss
-
Thailand, Cambodia clash despite ceasefire hopes
RBGPF | -1.52% | 73.88 | $ | |
SCU | 0% | 12.72 | $ | |
BCC | 1.94% | 88.14 | $ | |
SCS | 0.66% | 10.58 | $ | |
NGG | -0.11% | 72.15 | $ | |
CMSD | 0.17% | 22.89 | $ | |
RELX | -1.86% | 52.73 | $ | |
GSK | -0.68% | 37.97 | $ | |
RIO | -1.16% | 63.1 | $ | |
CMSC | 0.24% | 22.485 | $ | |
RYCEF | -0.3% | 13.2 | $ | |
BTI | -0.71% | 52.25 | $ | |
VOD | -0.79% | 11.43 | $ | |
JRI | -0.46% | 13.09 | $ | |
BP | 0.22% | 32.2 | $ | |
BCE | -0.95% | 24.2 | $ | |
AZN | -1.4% | 72.66 | $ |

US approves first blood test for Alzheimer's
The United States on Friday approved the first blood test for Alzheimer's, a move that could help patients begin treatment earlier with newly approved drugs that slow the progression of the devastating neurological disease.
The test, developed by Fujirebio Diagnostics, measures the ratio of two proteins in the blood. The rato is correlated with amyloid plaques in the brain -- a hallmark of Alzheimer's that, until now, has been detected only through brain scans or spinal fluid analysis.
"Alzheimer's disease impacts too many people -- more than breast cancer and prostate cancer combined," said Food and Drug Administration Commissioner Marty Makary.
"Knowing that 10 percent of people aged 65 and older have Alzheimer's, and that by 2050 that number is expected to double, I am hopeful that new medical products such as this one will help patients."
There are currently two FDA approved treatments for Alzheimer's: lecanemab and donanemab, which target amyloid plaque and have been shown to modestly slow cognitive decline, though they do not cure the disease.
Advocates for the intravenous antibody therapies, including many neurologists, say they can offer patients a few additional months of independence -- and are likely to be more effective if started earlier in the disease's course.
In clinical studies, the blood test produced results largely in line with positron emission tomography (PET) brain scans and spinal fluid analysis.
"Today's clearance is an important step for Alzheimer's diagnosis, making it easier and potentially more accessible for US patients earlier in the disease," said Michelle Tarver of the FDA's Center for Devices and Radiological Health.
The test is authorized for use in clinical settings for patients showing signs of cognitive decline, and results must be interpreted alongside other clinical information.
Alzheimer's is the most common form of dementia. It worsens over time, gradually robbing people of their memories and independence.
A.Ruiz--AT